Related Experiment Videos
Growth factors in human ovarian cancer
A M Westermann1, J H Beijnen, W H Moolenaar
1Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cancer Treatment Reviews
|March 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intraperitoneal treatment for advanced ovarian cancer, the Dutch experience. What did we learn?
The Netherlands journal of medicine·2020
[Making better use of the clinical geneticist's expertise; treating physician could request a DNA test for most cancer patients].
Nederlands tijdschrift voor geneeskunde·2017
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
European journal of cancer (Oxford, England : 1990)·2012
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
[Miltefosine: a new remedy for leishmaniasis].
Nederlands tijdschrift voor geneeskunde·2006
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.
Cancer treatment reviews·2026
Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.
Cancer treatment reviews·2026
Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.
Cancer treatment reviews·2026
Non-coding RNAs as regulators of chromosomal instability in breast cancer.
Frontiers in oncology·2026
IBD-related inflammatory memory and colorectal cancer: epigenetic mechanisms and microbiome interventions.
Frontiers in immunology·2026